You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Fulvestrant for the treatment of locally advanced or metastatic breast cancer

  • Technology appraisal guidance
  • Reference number: TA239
  • Published:  14 December 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Breast cancer (metastatic) - fulvestrant: consultee and commentator comments on the ACD

  • Breast cancer (metastatic) - fulvestrant: AstraZeneca

  • Breast cancer (metastatic) - fulvestrant: Breakthrough Breast Cancer

  • Breast cancer (metastatic) - fulvestrant: Royal College of Nursing

  • Breast cancer (metastatic) - fulvestrant: joint comment from National Cancer Research Institute, Royal College of Physician, Royal College of Radiologists, Association of Cancer Physicians and Joint Collegiate Council for Oncology

  • Breast cancer (metastatic) - fulvestrant: South Staffordshire PCT

  • Breast cancer (metastatic) - fulvestrant: Commissioning Support Appraisals Service


This page was last updated: 09 November 2011

Back to top